Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Adelaide A Hebert

11PUBLICATIONS
35CO-AUTHORS
Fluid-structure interaction and aeroacousticsDisease surveillanceInfant and child healthClinical pharmacology and therapeuticsAllergy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

Sort by Publication Date:
|Jun 11, 2026
Roflumilast foam versus vehicle foam for seborrheic dermatitis (STRATUM clinical study): a plain language summary.

|Jun 11, 2026
Long-term treatment of atopic dermatitis with roflumilast cream 0.15% in patients aged 6 years or older (INTEGUMENT-OLE clinical study): a plain language summary.

|Mar 08, 2026
Long-Term Safety and Efficacy of Once-Daily and Proactive Twice-Weekly Roflumilast Cream 0.05% for Mild-to-Moderate Atopic Dermatitis in Children Aged 2-5 Years From a 52-Week, Phase 3 Trial (INTEGUMENT-OLE).

Lawrence F Eichenfield, Mercedes E Gonzalez, Mark Boguniewicz

|Aug 27, 2025
Early Evidence of Safety, Clinical Benefit, and Pharmacokinetics of Roflumilast Cream 0.3% Once Daily for Treatment of Mild or Moderate Plaque Psoriasis in Children Aged 2-11 Years.

Adelaide A Hebert, Shireen V Guide, Vlada Groysman

|Jul 02, 2025
Characteristics and management of follicular events and contact dermatitis in patients using tapinarof cream for the treatment of atopic dermatitis or plaque psoriasis.

Linda Stein Gold, Matthew J Bruno, G Michael Lewitt

|Mar 24, 2025
Maximal Usage Trial of Tapinarof Cream 1% Once Daily in Pediatric Patients Down to 2 Years of Age with Extensive Atopic Dermatitis.

Amy S Paller, Adelaide A Hebert, Mercedes E Gonzalez

Pageof 2

Frequent Collaborators

3 joint publications

Erin Almaraz

3 joint publications

Lawrence F Eichenfield

3 joint publications

Mercedes E Gonzalez

2 joint publications

Melinda J Gooderham

2 joint publications

Stephen C Piscitelli

2 joint publications

David S Rubenstein

2 joint publications

Seth B Forman

2 joint publications

Vimal H Prajapati

2 joint publications

Kim A Papp

2 joint publications

Linda Stein Gold

Frequent Collaborators

3 joint publications

Erin Almaraz

3 joint publications

Lawrence F Eichenfield

3 joint publications

Mercedes E Gonzalez

2 joint publications

Melinda J Gooderham